ДОСВІД РОЗВИНУТИХ КРАЇН ІЗ ЗАЛУЧЕННЯ ФАРМАЦЕВТІВ І ПРОВІЗОРІВ ДО ПРОФІЛАКТИКИ ТА ЛІКУВАННЯ ЦУКРОВОГО ДІАБЕТУ

  • Білан О. А. старший викладач, Кафедра фармацевтичного менеджменту, клінічної фармації, технології ліків, ПВНЗ «Київський медичний університет», Київ, Україна https://orcid.org/0000-0002-2720-6864
  • Кухар О. О. к.фарм.н., доцент, Кафедра фармацевтичного менеджменту, клінічної фармації, технології ліків, ПВНЗ «Київський медичний університет», Київ, Україна https://orcid.org/0000-0002-2785-4001
  • Новикова Л. Г. старший викладач, Кафедра фармацевтичного менеджменту, клінічної фармації, технології ліків, ПВНЗ «Київський медичний університет», Київ, Україна https://orcid.org/0000-0001-5103-1016
Keywords: diabetes, new roles of clinical pharmacist, management and self-management of diabetes, prevention of diabetes complications, continuing pharmacy professional development

Abstract

The prevalence of diabetes mellitus (DM) in the world in general, and in Ukraine in particular, is increasingly showing signs of an epidemic. This chronic disease contributes significantly to increased spending on health care services due to severe complications, loss of capacity to work and increased mortality. Medical specialists see a way out of the crisis as providing patients with the opportunity to manage their disease on their own — in partnership with pharmaceutical specialists, namely, clinical care providers. Traditionally, the role of the pharmacist has been focused on delivering medicines and advising patients on medication, but recently, pharmaceutical professionals have started to become more involved in the management system of type I and type II DM by providing pharmaceutical care (PhС) to patients, thus optimizing treatment, improving clinical outcomes and reducing costs.

References

Clinical Pharmacy Education, Practice & Research. Ed. by D. Thomas. Elsevier; 1 edition, 2018. DOI https://doi.org/10.1016/C2017-0-01328-9

Diabetes in practice for pharmacists www.diabetesqualified.com.au/course/pharmacists. Diabetes Webinar Series http://www.diabetesqualified.com.au/course/diabetes-webinar-series.

IDF Diabetes Atlas, 9th edition, 2019 (https://diabetesatlas.org/en/resources).

Margaret A. Powers, Joan Bardsley, Marjorie Cypress, Paulina Duker, Martha M. Funnell, Amy Hess Fischl, Melinda D. Maryniuk, Linda Siminerio, and Eva Vivian. Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Clin Diabetes. 2016 Apr; 34(2): 70–80. doi: 10.2337/diaclin.34.2.70

Marie Smith, Pharmacists’ Role in Improving Diabetes Medication Management. Journal of Diabetes Science and Technology Volume 3, Issue 1, January 2009 doi: 10.1177/193229680900300120 PMCID: PMC2769842 PMID: 20046662

Pousinho S, Morgado M, Falcao A, et al: Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials. J Manag Care Spec Pharm 2016;22:493-515

Redesigning the health care team: Diabetes prevention and lifelong management. NIH Publication No. 11- 7739 NDEP-37. Bethesda, MD: National Diabetes Education Program; Revised June 2011. Retrieved from https://www.chcact.org/resource-files/DIABETEsPREVENTIONLIFELONGMNGMNT.pdf

Team Care Approach for Diabetes Management. Working Together to Manage Diabetes: A guide for pharmacy, podiatry, optometry, and dentistry. Retrieved from http://www.cdc.gov/diabetes/ndep/pdfs/ppod-guide-team-care-approach.pdf

The IDF School of Diabetes, IDF Certified Course for Diabetes Educators (http://www.idfdiabeteschool.org).

Wang Y., Yeo Q. Q., Ko Y., Economic evaluations of pharmacist‐managed services in people with diabetes mellitus: a systematic review. Diabetic Medicine, Volume 33, Issue 4, April 2016, Pages 421-427 https://doi.org/10.1111/dme.12976.

Wubben D.P., Vivian E.M. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008 Apr;28(4):421-36. doi: 10.1592/phco.28.4.421.

Views:

219

Downloads:

239

Published
2020-05-31
Citations
How to Cite
Білан О. А., Кухар О. О., & Новикова Л. Г. (2020). ДОСВІД РОЗВИНУТИХ КРАЇН ІЗ ЗАЛУЧЕННЯ ФАРМАЦЕВТІВ І ПРОВІЗОРІВ ДО ПРОФІЛАКТИКИ ТА ЛІКУВАННЯ ЦУКРОВОГО ДІАБЕТУ. World Science, 2(5(57), 49-54. https://doi.org/10.31435/rsglobal_ws/31052020/7080

Most read articles by the same author(s)